NIAID- VRC- Research, Development, and Production to Support Clinical Trials for HIV Vaccines.
NIAID- VRC- Research, Development, and Production to Support Clinical Trials for HIV Vaccines.
批准号:
10722425
负责人:
DAVID LINDSAY
金额:
$1014.32万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-04-12 至 2027-07-17
关键词:
Biological AssayClinicClinical TrialsDevelopmentHIV vaccineHealthHumanLaboratoriesMissionNational Institute of Allergy and Infectious DiseasePhaseProductionResearchTestingToxicologyUnited States National Institutes of HealthVaccine ResearchVaccineshuman diseaseimprovedlarge scale productionmanufacturing processmeetingsresearch and developmentvaccine development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Dale and Betty Bumpers Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), at the National Institutes of Health, was established to facilitate research in vaccine development and is dedicated to improving global human health through the rigorous pursuit of effective vaccines and treatments for human diseases. One of the key components of the VRC's mission involves the rapid advancement of promising candidates from the laboratory to the clinic. Meeting this mission necessitates the development and manufacturing of vaccines for toxicology, and Phase 1/11 clinical trials.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NIAID-VRC- Rapid Manufacturing Response
-
批准号:10722383
-
项目类别:
-
资助金额:$982.24万
-
财政年份:2022
-
负责人:DAVID LINDSAY
-
依托单位:
NIAID- VRC HIV mAb-Research, Development, and Production to Support HIV Monoclonal Antibody Development
-
批准号:10722410
-
项目类别:
-
资助金额:$1314.53万
-
财政年份:2022
-
负责人:DAVID LINDSAY
-
依托单位:
Anti-HIV Broadly Neutralizing Monoclonal Antibody (bnAbs) Drug Substance (DS) Clinical Trial Material Production and Release
-
批准号:10025661
-
项目类别:
-
资助金额:$589.77万
-
财政年份:2018
-
负责人:DAVID LINDSAY
-
依托单位:
Research, Development and Production to Support Clinical Trials for HIV Vaccines
-
批准号:9368890
-
项目类别:
-
资助金额:$530.0万
-
财政年份:2016
-
负责人:DAVID LINDSAY
-
依托单位:
海外基金